EW Edwards Lifesciences Corp

  1. Stocks
  2. Healthcare
  3. NYSE: EW

Price (delayed)

$69.49

Market cap

$42.11B

P/E Ratio

29.57

Dividend/share

N/A

EPS

$2.35

Enterprise value

$41.39B

Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of ...

Highlights
The price to earnings (P/E) is 38% lower than the 5-year quarterly average of 47.4 and 13% lower than the last 4 quarters average of 33.9
EW's revenue is up by 8% year-on-year and by 2.9% since the previous quarter
EW's quick ratio is down by 18% year-on-year but it is up by 7% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: https://www.edwards.com
Peers: BSX MMSI LMAT ICUI

Key stats

What are the main financial stats of EW
Market
Shares outstanding
606M
Market cap
$42.11B
Enterprise value
$41.39B
Valuations
Price to earnings (P/E)
29.57
Price to book (P/B)
6.35
Price to sales (P/S)
7.25
EV/EBIT
25.1
EV/EBITDA
22.74
EV/Sales
7.11
Earnings
Revenue
$5.82B
EBIT
$1.65B
EBITDA
$1.82B
Free cash flow
$808.4M
Per share
EPS
$2.35
Free cash flow per share
$1.33
Book value per share
$10.95
Revenue per share
$9.59
TBVPS
$12.59
Balance sheet
Total assets
$9.37B
Total liabilities
$2.64B
Debt
$691.1M
Equity
$6.66B
Working capital
$2.83B
Liquidity
Debt to equity
0.1
Current ratio
3.28
Quick ratio
2.15
Net debt/EBITDA
-0.4
Margins
EBITDA margin
31.3%
Gross margin
78%
Net margin
24.6%
Operating margin
26.7%
Efficiency
Return on assets
16.2%
Return on equity
23.1%
Return on invested capital
28.9%
Return on capital employed
20.3%
Return on sales
28.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

EW stock price

How has the Edwards Lifesciences stock price performed over time
Intraday
0.93%
1 week
3.06%
1 month
3.56%
1 year
-3.85%
YTD
-6.86%
QTD
0.3%

Financial performance

How have Edwards Lifesciences's revenue and profit performed over time
Revenue
$5.82B
Gross profit
$4.54B
Operating income
$1.56B
Net income
$1.43B
Gross margin
78%
Net margin
24.6%
The company's operating margin fell by 12% YoY
The net margin has contracted by 10% YoY
EW's revenue is up by 8% year-on-year and by 2.9% since the previous quarter
EW's gross profit is up by 7% year-on-year

Growth

What is Edwards Lifesciences's growth rate over time

Valuation

What is Edwards Lifesciences stock price valuation
EW P/E details
P/E
29.57
P/B
6.35
P/S
7.25
EV/EBIT
25.1
EV/EBITDA
22.74
EV/Sales
7.11
The price to earnings (P/E) is 38% lower than the 5-year quarterly average of 47.4 and 13% lower than the last 4 quarters average of 33.9
The company's EPS rose by 3.5% QoQ
The stock's price to book (P/B) is 41% less than its 5-year quarterly average of 10.7 and 20% less than its last 4 quarters average of 7.9
The equity has grown by 7% year-on-year and by 4.4% since the previous quarter
The P/S is 33% below the 5-year quarterly average of 10.9 and 18% below the last 4 quarters average of 8.8
EW's revenue is up by 8% year-on-year and by 2.9% since the previous quarter

Efficiency

How efficient is Edwards Lifesciences business performance
The company's return on sales fell by 11% YoY
Edwards Lifesciences's return on equity has decreased by 6% YoY
EW's return on assets is down by 6% year-on-year
The company's return on invested capital fell by 4% YoY but it rose by 2.1% QoQ

Dividends

What is EW's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for EW.

Financial health

How did Edwards Lifesciences financials performed over time
EW's quick ratio is down by 18% year-on-year but it is up by 7% since the previous quarter
The company's current ratio fell by 14% YoY but it rose by 4.1% QoQ
The debt is 90% less than the equity
The company's debt to equity fell by 9% QoQ and by 9% YoY
The equity has grown by 7% year-on-year and by 4.4% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.